Berger Dietmar
SEC CIK 1739515 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | Chief Medical Off | 19.8K | — | — | 9 | 2026-01-02 | 2026-09-10 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-11 18:29 | 2026-09-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | M - OptEx | — | +533 | 19.8K | +3% | — |
| D | 2026-09-11 18:29 | 2026-09-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | F - Tax | $144.81 | -263 | 19.5K | -1% | -$38.1K |
| D | 2026-06-11 18:35 | 2026-06-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | M - OptEx | — | +533 | 19.5K | +3% | — |
| D | 2026-06-11 18:35 | 2026-06-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | F - Tax | $121.48 | -263 | 19.3K | -1% | -$31.9K |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | M - OptEx | — | +2,133 | 20.0K | +12% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | F - Tax | $148.56 | -1,063 | 19.0K | -5% | -$157.9K |
| 2026-03-02 | 2026-02-27 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | A - Grant | $0.00 | +8,530 | 17.9K | +91% | $0 | |
| D | 2026-01-05 | 2026-01-02 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | M - OptEx | — | +16.3K | 16.3K | New | — |
| D | 2026-01-05 | 2026-01-02 | GILD | Gilead Sciences | Berger Dietmar | Chief Medical Off | F - Tax | $121.60 | -6,944 | 9,382 | -43% | -$844.4K |
Purchase Sale Sale after option exercise All abbreviations